Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Gyre Therapeutics Inc (GYRE)

Gyre Therapeutics Inc (GYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Gyre Therapeutics Inc 12770 HIGH BLUFF DRIVE SUITE 150 SAN DIEGO CA 92130 USA

www.gyretx.com Employees: 579 P: 858-567-7770

Sector:

Medical

Description:

Gyre Therapeutics Inc. is a biotechnology company. It focused on organ fibrosis and inflammatory diseases. The company's product pipeline primarily includes F573, F528 and F230. Gyre Therapeutics Inc., formerly known as Catalyst Biosciences Inc., is based in United States.

Key Statistics

Overview:

Market Capitalization, $K 692,634
Enterprise Value, $K 680,824
Shares Outstanding, K 96,333
Annual Sales, $ 105,760 K
Annual Net Income, $ 12,090 K
Last Quarter Sales, $ 30,560 K
Last Quarter Net Income, $ 3,610 K
EBIT, $ 12,030 K
EBITDA, $ 13,620 K
60-Month Beta 1.96
% of Insider Shareholders 10.00%
% of Institutional Shareholders 23.99%
Float, K 86,700
% Float 90.00%
Short Interest 1,471
Short Float 1.53%
Short Volume Ratio 0.54

Growth:

1-Year Return -44.10%
3-Year Return -9.13%
5-Year Return -92.40%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 100.14%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.06 on 11/07/25
Next Earnings Date 03/16/26
Earnings Per Share ttm 0.08
EPS Growth vs. Prev Qtr 150.00%
EPS Growth vs. Prev Year 150.00%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Most Recent Dividend 0.569 on 08/20/15
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 10/31/23

GYRE Ratios

Ratio
Price/Earnings ttm 89.75
Price/Earnings forward 35.90
Price/Earnings to Growth N/A
Return-on-Equity % 9.50%
Return-on-Assets % 7.87%
Profit Margin % 11.43%
Debt/Equity 0.00
Price/Sales 6.54
Price/Cash Flow 36.35
Price/Book 5.03
Book Value/Share 1.43
Interest Coverage -1.32
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar